Raadi (Wararka)

Forget Ozempic: This Obesity‐Drug Giant Is Grabbing the Biggest Slice of the GLP‐1 Gold Rush

business

Ozempic's rival is generating blockbuster revenue and gaining market share.
2026-02-19 12:10:00